Latest BRAF Stories
ReportsnReports.com adds "Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023" to its store.
ReportsnReports.com adds “Colorectal Cancer – US Drug Forecast and Market Analysis to 2023” to its store.
SAN DIEGO, Dec. 4, 2014 /PRNewswire/ -- Trovagene, Inc.
SAN DIEGO, Nov. 6, 2014 /PRNewswire/ -- Trovagene, Inc.
Prospective blinded study demonstrates ability to accurately determine mutational status and monitor response to BRAF inhibitor therapy from urinary cell-free DNA SAN DIEGO, Oct.
NEW YORK, Oct.
BRAF V600E assay improves determination of mutational status and allows monitoring of treatment response SAN DIEGO, Oct.
- Median overall survival is encouraging for this patient population - BOULDER, Colo., Sept.
- To give a box on the ear to.